Trials / Completed
CompletedNCT05556941
Metacognitive Intervention for Individuals With Severe Mental Disorders
Development and Efficacy of Metacognitive Intervention for Individuals With Severe Mental Disorders
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 84 (actual)
- Sponsor
- University of Haifa · Academic / Other
- Sex
- All
- Age
- 23 Years – 68 Years
- Healthy volunteers
- Not accepted
Summary
The overall aim of this study was to develop a meta-cognitive group intervention in order to apply it and to understand and distinguish the components that influence participation among people with schizophrenia
Detailed description
The overall aim of this study was to develop a Meta cognitive group intervention in order to apply it and to understand and distinguish the components that influence participation among people with schizophrenia. The specific objectives were to: 1. Improve participation by increasing the effectiveness of cognitive strategy use and teaching clients to independently review performance and to examine the strategy's effectiveness. 2. Compare the use of cognitive strategies between participants with schizophrenia and their matched controls following the Meta cognitive group intervention and to correlate the cognitive strategies use and participation following the Meta cognitive group. 3. Examine whether symptoms moderate the association between metacognitive outcomes and participation among people with schizophrenia following the Meta cognitive group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Metacognitive Group Intervention | The investigators developed an initial Meta cognitive group intervention protocol based on the dynamic interactional model of cognition (Toglia, 2005), and specifically tailored it to individuals with schizophrenia. |
| BEHAVIORAL | Occupational therapy standard care | Occupational therapy standard care |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2016-04-30
- Completion
- 2016-04-30
- First posted
- 2022-09-27
- Last updated
- 2022-10-03
Source: ClinicalTrials.gov record NCT05556941. Inclusion in this directory is not an endorsement.